Difficulty distribution
How the classified questions are distributed by difficulty.
Your cart is empty.
Practice Recombinant DNA technology and Other Tools in Biotechnology - Biotechnology previous year questions organised from real papers, with year-wise coverage and clear topic navigation.
Every graph below is calculated only from this selection.
Year-wise coverage for Recombinant DNA technology and Other Tools in Biotechnology. Each bar uses a separate theme-derived color.
How the classified questions are distributed by difficulty.
MCQ, numerical, multiple-select and other formats found in these papers.
Top subjects by unique question coverage.
Top topics across the included previous year papers.
Top subtopics inside this exact selection.
Question coverage for the most populated papers. Every active PYP paper remains listed below.
Open a focused page built from the same verified paper data.
Explore previous-paper coverage, trends and focused practice for Molecular tools.
Explore previous-paper coverage, trends and focused practice for Computational tools.
Explore previous-paper coverage, trends and focused practice for Recombinant DNA technology.
Explore previous-paper coverage, trends and focused practice for Analytical tools.
Newest papers appear first. Sort by year, question coverage or name.
| Paper | Year / session | Questions in this view | Open |
|---|---|---|---|
| Biotechnology (BT) 2024 | 2024 | 1 | View paper |
| Biotechnology (BT) 2023 | 2023 | 1 | View paper |
| Biotechnology (BT) 2013 | 2013 | 13 | View paper |
| Biotechnology (BT) 2012 | 2012 | 10 | View paper |
A varied preview from the papers represented in this selection, with every available option.
The first humanized monoclonal antibody approved for the treatment of breast cancers
In hybridoma technology, which one of the following enzymes is absent in the myeloma cells that are used for monoclonal antibody production?
Which one of the following is the basic principle of Sanger’s DNA sequencing method?